首页> 外文期刊>British journal of clinical pharmacology >Pragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery
【24h】

Pragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery

机译:实用药理学:使用心脏手术后儿童的残留样品进行芬太尼的总体药代动力学分析

获取原文
       

摘要

Aims One barrier contributing to the lack of pharmacokinetic (PK) data in paediatric populations is the need for serial sampling. Analysis of clinically obtained specimens and data may overcome this barrier. To add evidence for the feasibility of this approach, we sought to determine PK parameters for fentanyl in children after cardiac surgery using specimens and data generated in the course of clinical care, without collecting additional blood samples. Methods We measured fentanyl concentrations in plasma from leftover clinically-obtained specimens in 130 paediatric cardiac surgery patients and successfully generated a PK dataset using drug dosing data extracted from electronic medical records. Using a population PK approach, we estimated PK parameters for this population, assessed model goodness-of-fit and internal model validation, and performed subset data analyses. Through simulation studies, we compared predicted fentanyl concentrations using model-driven weight-adjusted per kg vs . fixed per kg fentanyl dosing. Results Fentanyl clearance for a 6.4 kg child, the median weight in our cohort, is 5.7 l h–1 (2.2–9.2 l h–1), similar to values found in prior formal PK studies. Model assessment and subset analyses indicated the model adequately fit the data. Of the covariates studied, only weight significantly impacted fentanyl kinetics, but substantial inter-individual variability remained. In simulation studies, model-driven weight-adjusted per kg fentanyl dosing led to more consistent therapeutic fentanyl concentrations than fixed per kg dosing. Conclusions We show here that population PK modelling using sparse remnant samples and electronic medical records data provides a powerful tool for assessment of drug kinetics and generation of individualized dosing regimens.
机译:目的导致缺乏儿科人群药代动力学(PK)数据的一个障碍是需要进行连续采样。对临床获得的标本和数据进行分析可以克服这一障碍。为了增加这种方法的可行性的证据,我们试图在心脏手术后使用标本和临床护理过程中生成的数据确定儿童芬太尼的PK参数,而无需收集其他血液样本。方法我们测量了130名小儿心脏外科手术患者的临床残留标本中血浆中的芬太尼浓度,并使用从电子病历中提取的药物剂量数据成功生成了PK数据集。使用总体PK方法,我们估计了该群体的PK参数,评估了模型的拟合优度和内部模型验证,并进行了子集数据分析。通过模拟研究,我们比较了模型驱动的重量调整的每千克vs.的芬太尼浓度预测值。每公斤固定芬太尼剂量。结果6.4公斤儿童的芬太尼清除率(该队列中的中位体重)为5.7 lh -1 (2.2-9.2 lh -1 ),与之前的数值相似正式的PK研究。模型评估和子集分析表明模型足以拟合数据。在研究的协变量中,只有体重显着影响芬太尼动力学,但个体间仍存在较大差异。在模拟研究中,模型驱动的每公斤芬太尼剂量调整后的体重调整后的芬太尼浓度比固定的每公斤剂量产生更一致的治疗芬太尼浓度。结论我们在此表明​​,使用稀疏残留样品和电子病历数据进行的人口PK模型为评估药物动力学和个性化给药方案提供了强大的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号